Clinical Trial Update: Safety and Efficacy of SeeMore (TM) in Heart Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports completed safety and efficacy assessment for SeeMore in patients who have had a myocardial infarction, sponsored by Eagle Vision …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• SeeMore

Snippet

Sponsor: Eagle Vision Pharmaceutical Corp. | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED